| 摘要 |
The present application relates to new uses of 5-HT6 receptor antagonists, specifically high doses of 3-phenylsulfonyl-8-piperazinyl-1yl-quinoline, and to the combination of 5-HT6 receptor antagonists, specifically 3-phenylsulfonyl-8-piperazinyl-1yl-quinoline, with, an acetylcholinesterase inhibitor for the treatment of a neurodegenerative disease. |
| 申请人 |
AXOVANT SCIENCES LTD.;FRIEDHOFF, Lawrence Tim;PISCITELLI, Stephen Clement;KISHNANI, Kunal;RAMASWAMY, Shankar;LEWIS, Bryan M. |
发明人 |
FRIEDHOFF, Lawrence Tim;PISCITELLI, Stephen Clement;KISHNANI, Kunal;RAMASWAMY, Shankar;LEWIS, Bryan M. |
